Medivive
ActiveSummary
Medivive has been active since 2015 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €264k and a net result of €395k. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 16% of 16546 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2025
74
/ 100
Healthy
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability93▼-1
Solvency38▼-8
Growth58▼-20
Track record100
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €19k at 30 days acceptable
Liquidity short (current ratio 0.64 against 0.78 in 2024; short-term debt: 59.5% and cash: 26% of total assets), and 87.3% of the assets are financed with debt.
Credit check for your own amount and term
Signals
Four signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
12.7%
Return on assets
19%
Age of the figures
9 mo
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 16% of 16546 sector peers (2025).
NBB · sector comparisonPosition among 16546 sector peers
Solvency
better than 16%
← weakest
strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 22-07-2026, 9 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
9 d early
2024
20 d early
2023
26 d early
2022
45 d early
2021
38 d early
2020
16 d early
2019
28 d late
← before the deadline
after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
24-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€264k▼ 41.0%
2024 · €447k
2018: €290k
2019: €381k
2020: €671k
2021: €328k
2022: €20k
2023: €20k
2024: €447k
2018 → 2025
Total assets
€2.08M▼ 1.1%
2024 · €2.10M
2018: €1.18M
2019: €1.75M
2020: €1.93M
2021: €2.08M
2022: €1.67M
2023: €1.92M
2024: €2.10M
2018 → 2025
Net result
€395k▼ 7.3%
2024 · €426k
2018: €239k
2019: €141k
2020: €290k
2021: €257k
2022: €349k
2023: €434k
2024: €426k
2018 → 2025
Working capital
€-443k▼ 114%
2024 · €-208k
2018: €167k
2019: €275k
2020: €419k
2021: €12k
2022: €-443k
2023: €-560k
2024: €-208k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€328k-€20k▼ 93.8%€20k=€447k▲ 2,084%€264k▼ 41.0%
Operating result€365k-€484k▲ 32.8%€591k▲ 22.0%€585k▼ 1.1%€540k▼ 7.6%
Net result€257k-€349k▲ 35.7%€434k▲ 24.3%€426k▼ 1.7%€395k▼ 7.3%
Turnover and EBIT margin not published: the abbreviated or micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result has fallen two years in a row; 2025 is 8% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €2.08M
Fixed assets
€1.28M ▼ 4.8%
Current assets
€792k ▲ 5.5%
Equity and liabilities €2.08M
Equity
€264k ▼ 41.0%
Debt
€1.81M ▲ 9.6%
Debt's share of the balance-sheet total rises from 78.7% to 87.3%. Equity is lower and debt is higher.
Key figures and ratios
EBITDA
€605k▼
2024 · €648k
Cash flow
€460k▼
2024 · €490k
Current ratio
0.64▼
2024 · 0.78
Debt to equity
6.87▲
2024 · 3.70
ROE
149.8%▲
2024 · 95.4%
ROA
19.0%▼
2024 · 20.3%
Interest coverage
36.81▲
2024 · 33.62
Debt ≤ 1 year
€1.24M▲
2024 · €958k
Debt > 1 year
€577k▼
2024 · €695k
Income taxes
€131k▼
2024 · €140k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 50 lines
Balance sheet
Code20242025
Assets
Total assets20/58€2.10M€2.08M▼
Fixed assets21/28€1.35M€1.28M▼
Tangible fixed assets22/27€1.35M€1.28M▼
Land and buildings22€1.19M€1.15M▼
Plant, machinery and equipment23€14k€12k▼
Furniture and vehicles24€146k€125k▼
Financial fixed assets28€245€245=
Current assets29/58€751k€792k▲
Amounts receivable within one year40/41€270k€247k▼
Trade receivables40€270k€238k▼
Other amounts receivable41€0€9k▲
Current investments50/53€100k€976▼
Cash at bank and in hand54/58€376k€541k▲
Deferred charges and accrued income490/1€4k€3k▼
Equity and liabilities
Total equity and liabilities10/49€2.10M€2.08M▼
Equity10/15€447k€264k▼
Contributions10/11€19k€19k=
Reserves13€428k€245k▼
Distributable reserves133€428k€245k▼
Profit (loss) carried forward14€0€0=
Amounts payable17/49€1.65M€1.81M▲
Amounts payable after more than one year17€695k€577k▼
Financial debts170/4€695k€577k▼
Amounts payable within one year42/48€958k€1.24M▲
Current portion of amounts payable after more than one year42€117k€158k▲
Financial debts43€34k€0▼
Credit institutions430/8€34k€0▼
Trade debts44€10k€4k▼
Suppliers440/4€10k€4k▼
Taxes, remuneration and social security45€42k€92k▲
Taxes450/3€42k€92k▲
Other amounts payable47/48€755k€982k▲
Income statement
Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€63k€65k▲
Other operating charges640/8€5k€4k▼
Gross operating margin9900€653k€610k▼
Operating profit (loss)9901€585k€540k▼
Financial income75/76B€1k€2k▲
Recurring financial income75€1k€2k▲
Financial charges65/66B€19k€16k▼
Recurring financial charges65€19k€16k▼
Profit (loss) for the period before taxes9903€567k€526k▼
Income taxes67/77€140k€131k▼
Profit (loss) for the period9904€426k€395k▼
Profit (loss) for the period to be appropriated9905€426k€395k▼
Appropriation of the result
Profit (loss) to be appropriated9906€426k€395k▼
Transfer from equity791/2-€428k
Transfer to equity691/2€426k€245k▼
To other reserves6921€426k€245k▼
Profit to be distributed694/7€0€578k▲
Return on contributions (dividend)694€0€578k▲
The notes to these accounts (12 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
22-07
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
11-07
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
31-12
Financial
Equity above €200kEq €447k ▲2084%
7 profitable years in a row build equity to €447k.
05-07
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
31-12
Financial
Highest result since 2018net €434k ▲24.3%
Operating result €591k, net result €434k, both a record.
16-06
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2022
23-06
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
2021
15-07
NBB filing
Annual accounts filed
fiscal year 2020 · abbreviated schema
2020
31-12
Financial
Equity above €500kEq €671k ▲76.2%
3 profitable years in a row build equity to €671k.
28-08
NBB filing
Annual accounts filed
fiscal year 2019 · abbreviated schema · 28 days late
2019
31-12
Financial
Weakest financial yearnet €141k ▼41.1%
Net result drops to €141k, the lowest in the series; recovery starts the following year.
14-08
NBB filing
Annual accounts filed
fiscal year 2018 · abbreviated schema · 14 days late
2018
29-06
NBB filing
Annual accounts filed
fiscal year 2017 · abbreviated schema
2017
28-06
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Roeselare · 1 establishment unit since 2015
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Sint-Eloois-Winkelsestraat 798800 RoeselareGround area
4,171 m²
Parcel 36013A0317/00A000, Flanders. Linked by address, not a title deed.
1 establishment unit
Dokter Thomas Ryckaert
since 20152.246.802.981
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 36013A0317/00A000 | Flanders | 4,171 m² | - | - |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
ESCULAPE
BE 0462.295.367
Waimes · Eq €263,751
MEDICAF
BE 0478.900.777
Elsene · Eq €263,777
AREX MEDICAL
BE 0737.645.210
Zaventem · Eq €263,797
NOSELE
BE 0876.435.778
Sint-Pieters-Woluwe · Eq €263,979
DOCTEUR KIROVA MARIA
BE 0723.426.592
Saint-Ghislain · Eq €264,005
Of 16,627 companies in sector 86220 we hold annual accounts for 7,974. 6,680 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded15-10-2015
Fiscal year end31-12
Activities, NACEBEL 2025
86220Specialist medical practice
70200Business and other management consultancy
Sources
Crossroads Bank for EnterprisesNational Bank · 11 filingsAddress and cadastre registers
Scores and ratios are computed by Checked and are not a credit decision.